Study of HARMONIC 700 Shears in Surgical Procedures
This study is looking at the HARMONIC 700 Shears, a device used in surgery to cut and seal blood vessels. The main goal is to see how well it works and if it's safe when used in children and adults during various surgical procedures, including gynecological, urological, and thoracic surgeries. Researchers will measure how effectively the device stops bleeding during surgery and track any device-related problems for up to about 1 year and 7 months. You may be able to join if you are having a non-emergency surgery where the HARMONIC 700 Shears will be used, and you are between 0 and 110 years old. The study is currently unclear on its recruitment status and plans to include 165 participants.
- Study design
- This is an observational study, meaning researchers will watch how the HARMONIC 700 Shears are used in real-world surgical settings. It aims to include 165 participants of all ages.
- What's involved
- There is no intervention beyond necessary clinical care in this study; the HARMONIC 700 Shears will be used as part of your planned surgery. Researchers will assess bleeding during surgery and monitor for device-related issues for up to approximately 1 year and 7 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for device-related adverse events for up to approximately 1 year and 7 months after their surgery.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Study of HARMONIC 700 Shears With Advanced Hemostasis in Pediatric and Adult Surgical Procedures
At a glance
Conditions
Where it's being run
7 sites across 4 statesStudy leadership
- Ethicon Endo-Surgery, Inc. Clinical Trial · STUDY_DIRECTOR · Ethicon Endo-Surgery, Inc.
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Number of Vessel Transections With an Achievement of Grade 3 or Lower HemostasisIntraoperative
Number of vessel transection with achievement of Grade 3 or lower hemostasis for each vessel transection will be reported as per the grading scale as follows- Grade 1: no bleeding at transection site; Grade 2: minor bleeding at transection site, no intervention needed; Grade 3: minor bleeding at transection site, mild intervention needed, use of compression, basic energy devices (monopolar and/or bipolar) and/or touch-ups with HARMONIC 700 Shears; Grade 4: significant bleeding (for example \[e.g.\], pulsatile blood flow, venous pooling) requiring intervention such as extensive coagulation or ligation with use of additional hemostatic measures.
- Number of Participants with Device-Related Adverse Events (AEs)Up to approximately 1 year and 7 months
An AE is defined as any untoward medical occurrence, regardless of its relationship to the study device or the study procedure. An untoward medical occurrence includes any new, undesirable medical experience or worsening of a pre-existing condition, which occurs throughout the duration of the clinical study.